During the last session, Foghorn Therapeutics Inc (NASDAQ:FHTX)’s traded shares were 0.45 million, with the beta value of the company hitting 3.12. At the end of the trading day, the stock’s price was $5.30, reflecting an intraday loss of -8.30% or -$0.48. The 52-week high for the FHTX share is $10.25, that puts it down -93.4 from that peak though still a striking 49.06% gain since the share price plummeted to a 52-week low of $2.70. The company’s market capitalization is $294.65M, and the average intraday trading volume over the past 10 days was 0.12 million shares, and the average trade volume was 156.34K shares over the past three months.
Foghorn Therapeutics Inc (FHTX) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.29. FHTX has a Sell rating from 0 analyst(s) out of 3 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.3.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Foghorn Therapeutics Inc (NASDAQ:FHTX) trade information
Foghorn Therapeutics Inc (FHTX) registered a -8.30% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -8.30% in intraday trading to $5.30, hitting a weekly high. The stock’s 5-day price performance is -19.33%, and it has moved by -40.11% in 30 days. Based on these gigs, the overall price performance for the year is -4.16%. The short interest in Foghorn Therapeutics Inc (NASDAQ:FHTX) is 0.89 million shares and it means that shorts have 7.62 day(s) to cover.
The consensus price target of analysts on Wall Street is $14.5, which implies an increase of 63.45% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $9 and $20 respectively. As a result, FHTX is trading at a discount of -277.36% off the target high and -69.81% off the low.
Foghorn Therapeutics Inc (FHTX) estimates and forecasts
Statistics show that Foghorn Therapeutics Inc has outperformed its competitors in share price, compared to the industry in which it operates. Foghorn Therapeutics Inc (FHTX) shares have gone up 0.95% during the last six months, with a year-to-date growth rate more than the industry average at 32.48% against 17.10. In the rating firms’ projections, revenue will decrease -13.86% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 8.14M as predicted by 4 analyst(s). Meanwhile, a consensus of 4 analyst(s) estimates revenue growth to 5.98M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 5.77M and 5.05M respectively. In this case, analysts expect current quarter sales to grow by 41.03% and then jump by 18.36% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -26.80%. While earnings are projected to return 30.22% in 2024.
FHTX Dividends
Foghorn Therapeutics Inc is due to release its next quarterly earnings in January. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Foghorn Therapeutics Inc (NASDAQ:FHTX)’s Major holders
Foghorn Therapeutics Inc insiders own 18.98% of total outstanding shares while institutional holders control 72.11%, with the float percentage being 89.01%. FLAGSHIP PIONEERING INC. is the largest shareholder of the company, while 114.0 institutions own stock in it. As of 2024-06-30, the company held over 12.67 million shares (or 29.8715% of all shares), a total value of $72.88 million in shares.
The next largest institutional holding, with 6.38 million shares, is of FMR LLC’s that is approximately 15.0447% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $36.7 million.
